Skip to main content
VCbacked
Log inGet Started

Calithera Biosciences

South San Francisco, United States

Calithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.

$10.0M raised
Mar 2022
Post-IPO Equity
BiotechnologyPharmaceuticalTherapeutics

Top Investors

U.S. Venture PartnersAdage Capital ManagementLongwood FundMission Bay CapitalCystic Fibrosis Foundation

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Calithera Biosciences

How much funding has Calithera Biosciences raised?
Calithera Biosciences has raised $10.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2022.
Who are Calithera Biosciences's investors?
Calithera Biosciences's investors include U.S. Venture Partners, Adage Capital Management, Longwood Fund, Mission Bay Capital, Cystic Fibrosis Foundation.
Where is Calithera Biosciences headquartered?
Calithera Biosciences is headquartered in South San Francisco, United States.
What does Calithera Biosciences do?
Calithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.
What stage is Calithera Biosciences at?
Calithera Biosciences is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Calithera Biosciences — Funding & Investors." VCBacked, March 30, 2022, https://www.vcbacked.co/company/calithera-biosciences. Accessed July 2, 2026.
APA
VCBacked. (2022). Calithera Biosciences — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/calithera-biosciences
Wikipedia (cite web)
{{cite web |title=Calithera Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/calithera-biosciences |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K